reviewBloodSep 1, 2002Closed access

The roles of FLT3 in hematopoiesis and leukemia

Howard Hughes Medical Institute · Dana-Farber Cancer Institute

PubMed
Indexed incrossrefpubmed

Abstract

FLT3 is a receptor tyrosine kinase expressed by immature hematopoietic cells and is important for the normal development of stem cells and the immune system. The ligand for FLT3 is expressed by marrow stromal cells and other cells and synergizes with other growth factors to stimulate proliferation of stem cells, progenitor cells, dendritic cells, and natural killer cells. Mutations of FLT3 have been detected in about 30% of patients with acute myelogenous leukemia and a small number of patients with acute lymphocytic leukemia or myelodysplastic syndrome. Patients with FLT3 mutations tend to have a poor prognosis. The mutations most often involve small tandem duplications of amino acids within the juxtamembrane…

Citation impact

1,554
total citations
FWCI
24.59
Percentile
100%
References
169
Citations per year

Authors

2

Topics & keywords

Keywords
  • Haematopoiesis
  • Biology
  • CD135
  • Cancer research
  • Leukemia
  • Stem cell
  • Fms-Like Tyrosine Kinase 3
  • Tyrosine kinase
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.